EW vs MAIN · P/E 47, rev $1.39B vs P/E 10, $5.44B cap
Edwards Lifesciences Corp (EW) versus Main Street Capital Corporation (MAIN) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Main Street Capital Corporation (MAIN) is a asset management company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
MAIN does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. MAIN currently screens at market cap $5.44B and trailing P/E 10.4.
Not investment advice. Open the EW and MAIN stock pages for the full models.
Not investment advice.